Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.

Plasticity of vascular smooth muscle cells (VSMCs) plays a central role in the onset and progression of proliferative vascular diseases. In adult tissue, VSMCs exist in a physiological contractile-quiescent phenotype, which is defined by lack of the ability of proliferation and migration, while high...

Full description

Bibliographic Details
Main Authors: Shuang Chen, Baoqin Liu, Dehui Kong, Si Li, Chao Li, Huaqin Wang, Yingxian Sun
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4398430?pdf=render
id doaj-84a6b7bb9e4f4682820201e3cc8df431
record_format Article
spelling doaj-84a6b7bb9e4f4682820201e3cc8df4312020-11-25T01:27:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012257710.1371/journal.pone.0122577Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.Shuang ChenBaoqin LiuDehui KongSi LiChao LiHuaqin WangYingxian SunPlasticity of vascular smooth muscle cells (VSMCs) plays a central role in the onset and progression of proliferative vascular diseases. In adult tissue, VSMCs exist in a physiological contractile-quiescent phenotype, which is defined by lack of the ability of proliferation and migration, while high expression of contractile marker proteins. After injury to the vessel, VSMC shifts from a contractile phenotype to a pathological synthetic phenotype, associated with increased proliferation, migration and matrix secretion. It has been demonstrated that PDGF-BB is a critical mediator of VSMCs phenotypic switch. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-3-methyl-glutaryl l coenzyme A (HMG-CoA) reductase, exhibits various protective effects against VSMCs. In this study, we investigated the effects of atorvastatin calcium on phenotype modulation of PDGF-BB-induced VSMCs and the related intracellular signal transduction pathways. Treatment of VSMCs with atorvastatin calcium showed dose-dependent inhibition of PDGF-BB-induced proliferation. Atorvastatin calcium co-treatment inhibited the phenotype modulation and cytoskeleton rearrangements and improved the expression of contractile phenotype marker proteins such as α-SM actin, SM22α and calponin in comparison with PDGF-BB alone stimulated VSMCs. Although Akt phosphorylation was strongly elicited by PDGF-BB, Akt activation was attenuated when PDGF-BB was co-administrated with atorvastatin calcium. In conclusion, atorvastatin calcium inhibits phenotype modulation of PDGF-BB-induced VSMCs and activation of the Akt signaling pathway, indicating that Akt might play a vital role in the modulation of phenotype.http://europepmc.org/articles/PMC4398430?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Shuang Chen
Baoqin Liu
Dehui Kong
Si Li
Chao Li
Huaqin Wang
Yingxian Sun
spellingShingle Shuang Chen
Baoqin Liu
Dehui Kong
Si Li
Chao Li
Huaqin Wang
Yingxian Sun
Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
PLoS ONE
author_facet Shuang Chen
Baoqin Liu
Dehui Kong
Si Li
Chao Li
Huaqin Wang
Yingxian Sun
author_sort Shuang Chen
title Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
title_short Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
title_full Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
title_fullStr Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
title_full_unstemmed Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway.
title_sort atorvastatin calcium inhibits phenotypic modulation of pdgf-bb-induced vsmcs via down-regulation the akt signaling pathway.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Plasticity of vascular smooth muscle cells (VSMCs) plays a central role in the onset and progression of proliferative vascular diseases. In adult tissue, VSMCs exist in a physiological contractile-quiescent phenotype, which is defined by lack of the ability of proliferation and migration, while high expression of contractile marker proteins. After injury to the vessel, VSMC shifts from a contractile phenotype to a pathological synthetic phenotype, associated with increased proliferation, migration and matrix secretion. It has been demonstrated that PDGF-BB is a critical mediator of VSMCs phenotypic switch. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-3-methyl-glutaryl l coenzyme A (HMG-CoA) reductase, exhibits various protective effects against VSMCs. In this study, we investigated the effects of atorvastatin calcium on phenotype modulation of PDGF-BB-induced VSMCs and the related intracellular signal transduction pathways. Treatment of VSMCs with atorvastatin calcium showed dose-dependent inhibition of PDGF-BB-induced proliferation. Atorvastatin calcium co-treatment inhibited the phenotype modulation and cytoskeleton rearrangements and improved the expression of contractile phenotype marker proteins such as α-SM actin, SM22α and calponin in comparison with PDGF-BB alone stimulated VSMCs. Although Akt phosphorylation was strongly elicited by PDGF-BB, Akt activation was attenuated when PDGF-BB was co-administrated with atorvastatin calcium. In conclusion, atorvastatin calcium inhibits phenotype modulation of PDGF-BB-induced VSMCs and activation of the Akt signaling pathway, indicating that Akt might play a vital role in the modulation of phenotype.
url http://europepmc.org/articles/PMC4398430?pdf=render
work_keys_str_mv AT shuangchen atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway
AT baoqinliu atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway
AT dehuikong atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway
AT sili atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway
AT chaoli atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway
AT huaqinwang atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway
AT yingxiansun atorvastatincalciuminhibitsphenotypicmodulationofpdgfbbinducedvsmcsviadownregulationtheaktsignalingpathway
_version_ 1725107545039699968